BT-GSI, a gamma-secretase inhibitor (GSI) with bone-targeting capabilities, effectively inhibits Notch signaling. Exhibiting dual action, it possesses both anti-myeloma and anti-resorptive properties, making it a promising candidate for research into multiple myeloma and related bone diseases. Additionally, BT-GSI demonstrates potential in inhibiting tumor growth and the progression of osteolytic disease.
Molecular Weight:
730.52
Formula:
C26H46BrN5O10P2
Target:
Others|||Gamma-secretase
T73485
* VAT and and shipping costs not included. Errors and price changes excepted
